Synthesis & Antifungal Screening of Novel Azetidin-2-ones

Apoorva Gupta*, Anand K. Halve
School of Studies in chemistry, Jiwaji University Gwalior-474011, India

Article Metrics

CrossRef Citations:
Total Statistics:

Full-Text HTML Views: 2209
Abstract HTML Views: 1442
PDF Downloads: 431
Total Views/Downloads: 4263
Unique Statistics:

Full-Text HTML Views: 1250
Abstract HTML Views: 866
PDF Downloads: 306
Total Views/Downloads: 2555

Creative Commons License
© Gupta and Halve; Licensee Bentham Open.

open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

* Address correspondence to this author at the School of Studies in Chemistry, Jiwaji University Gwalior-474011, India; Tel: 8305962885; E-mail:


A new series of 4-[3-chloro-2-(4-hydroxy-3-methoxybenzyllidene)-4-oxoazetidin-1-yl]amino-N-(substituted)benzenesulfonamide, 4-{3-chloro-2-[5-methoxy-2-nitro-4-(prop-2-en-1-yloxy)benz yllidene]-4-oxoazetidin-1-yl}]amino}-N-(substituted)benzenesulfonamide and 4-{3-chloro-2-[4-hydroxy-3-methoxy-5-(prop-2-en-1-yl)benzylidene]-4-oxoazetidin-1-yl}amino}-N-(substituted) benzenesulfonamide were synthesized using appropriate synthetic route. The chemical structures of all the synthesized compounds were deduced on the basis of elemental analysis and spectroscopic data. The antifungal activity of the synthesized compounds was screened against several fungus. The synthesized compounds show potent antifungal activity against Aspergillus niger & Aspergillus flavus and significant structure-activity relationship (SAR) trends.

Keywords: Aspergillus flavus, Azetidin-2-ones, SAR.


Heterocycles constitute one of the most significant areas of research in the field of medicinal chemistry [1]. The azetidin-2-ones (β-lactam) heterocycles are considered as an important contribution of science to humanity [2], since they have been constituents of living organisms, natural products, drugs and many more substances useful to mankind and society in all walks of life. Their synthesis and evaluation has always drawn the attention of chemists & biologists over the years [3]. Since the discovery of penicillins [4, 5], and cephalosporins as the most successful antibiotics, azetidin-2-ones have been the subject of regular discussion and investigation. The azetidin-2-ones antibiotics endowed with unique structure and potent antibacterial activity, include, penicillins, cephalosporins, carbapenems, nocardicins, clavulanic acid, sulbactams, and tazobactams. These molecules operate by forming a covalent adduct with membrane-bound bacterial transpeptidases, which are also known as penicillin binding proteins (PBPs), involved in the biosynthesis of cell walls. These mechanism-based inhibitors prevent the construction of cell wall and eventually lead to cell lysis and death. Moreover, due to their β-lactamase inhibitory action, azetidin-2-ones based heterocycles represent an attractive target of contemporary organic synthesis. Azetidin-2-ones and its derivatives are important compounds due to their broad range of biological activities such as antimicrobial, antiubercular, anticancer, cholesterol absorption inhibition, antidiabetic, analgesic and anti-inflammatory, thrombin inhibition, antiparkinsonian, vasopressin via antagonist, anticonvulsant [6-30].


All chemicals and solvents, reagents used in the present study were of analytical grade and solvents were used after distillation. All the melting points of the synthesized compounds were determined by open capillary and are uncorrected. The purity of the compounds was checked using precoated TLC plates (MERCK) using chloroform: ethyl acetate (8:2) solvent system. The developed chromatographic plates were visualized under UV at 254nm. IR spectra were recorded using KBr on Perkin Elmer spectrophotometer. 1HNMR spectra in DMSO on a BRUKER FT-NMR instrument using TMS as internal standard and chemical shift values were expressed in ppm. Elemental analysis (CHN) was performed on Carlo Erba 1108.

The present work is undertaken to explore more possibilities of finding a suitable derivative, which would exceed its activity more than the already known drugs containing azetidin-2-ones ring. With the alarming trends in fungal resistance to many azetidin-2-ones antibiotics it has become necessary to synthesize some novel azetidin-2-ones for bioassay of antifungal activity and the need for drugs with more specific antifungal activity. Therefore it was thought of interest to combine all the above-mentioned biolabile heterocyclic rings together in a molecular framework of imines in order to enhance the additive effect toward the biological activity. Keeping this in mind and in continuation of our earlier studies, we designed and synthesized 4-[3-chloro-2-(4-hydroxy-3-methoxybenzyllidene)-4-oxoazetidin-1-yl]amino-N-(substituted) benzenesulfonamide, 4-{3-chloro-2-[5-methoxy-2-nitro-4-(prop-2-en-1-yloxy) benzyllidene]-4-oxoazetidin-1-yl}]amino}-N-(substituted) benzenesulfonamide and 4-{3-chloro-2-[4-hydroxy-3-methoxy-5-(prop-2-en-1-yl)benzylidene]-4-oxoazetidin-1-yl}amino}-N-(substituted)benzene sulfonamide with fascinating structural features. Moreover, in order to assess the antifungal potentiality of azetidin-2-ones nucleus and to investigate the structure-activity-relationship, the constructed molecules were screened for their antifungal activities.

The synthetic pathway includes an electrocyclisation reaction of imine derivatives to give direct access to the desired 4-[3-chloro-2-(4-hydroxy-3-methoxybenzyllidene)-4-oxoazetidin-1-yl]amino-N-(substituted)benzenesulfonamide, 4-{3-chloro-2-[5-methoxy-2-nitro-4-(prop-2-en-1-yloxy)benzyllidene]-4-oxoazetidin-1-yl}]amino}-N-(substituted)benzenesulfonamide and 4-{3-chloro-2-[4-hydroxy-3-methoxy-5-(prop-2-en-1-yl)benzylidene]-4-oxoazetidin-1-yl} amino}-N-(substituted)benzenesulfonamide.

The approach involves the initial preparation of precursors 4-{[(E)-(4-hydroxy-3-methoxy benzyllidene] amino}-N-(substituted)benzenesulfonamide, 4-({((E)-[5 -methoxy- 2- nitro- 4- (prop -2 -en- 1 -yloxy) benzyllidene] amino}-N-(substituted)benzenesulfonamide and 4-{[(E)- (4-hydroxyl-3-methoxy-5-(prop-2-en-1-yl)benzylideneamino}-N-(substituted)benzenesulfon amide. The reactive imine derivatives were accessible via the reaction of an equimolar quantity of aromatic aldehyde containing allyl and allyloxy group with different sulpha drugs in ethanol at room temperature which resulted in the formation of 4-{[(E)-(4-hydroxy-3-methoxy benzyllidene] amino}-N-(substituted)benzenesulfonamide, 4-({((E)-[5 -methoxy- 2- nitro- 4- (prop -2 -en- 1 -yloxy) benzyllidene] amino}-N-(substituted)benzenesulfonamide and 4-{[(E)-(4-hydroxyl-3-methoxy-5-(prop-2-en-1-yl)benzylideneamino}-N-(substituted)benzene sulfonamide [31] in good yield.

Further, the initially formed reactive imines underwent an electrocyclisation reaction of chloroacetyl chloride and triethyl amine in 1,4-dioxane afforded the target compounds 4-[3-chloro-2-(4-hydroxy-3-methoxybenzyllidene)-4-oxoazetidin-1-yl]amino-N-(substituted) benzenesulfonamide,4-{3-chloro-2-[5-methoxy-2-nitro-4-(prop-2-en-1-yloxy) benzyllidene] -4-oxoazetidin-1-yl}]amino}-N-(substituted) benzenesulfonamide and 4-{3-chloro-2-[4-hydroxy-3-methoxy-5-(prop-2-en-1-yl)benzylidene]-4-oxoazetidin-1-yl}amino}-N-(substituted)benzene sulfonamide [32] in good yield. Typically, ketenes are generated thermally from acid chlorides in the presence of triethylamine, which on subsequent reaction with reactive imines yield the desired azetidin-2-ones [33].

General procedure for the synthesis of azetidinones: [3A-L]

Imine (0.001mole) was added to a constantly stirred solution of 1,4dioxane(15ml), triethylamine(0.001mole) and chloroacetylchloride(0.001mole). The reaction mixture was stirred at 50oC. The reaction vessel was then kept at room temperaturefor 30min and refluxed for 8hr. On cooling the precipitate was obtained, which was filtered and, thoroughly washed with water.


Structures of newly obtained compounds have been ascertained on the basis of their consistent IR, 1H NMR and elemental analysis assignments.

2(A) 4-{[(E)-(4-hydroxy-3-methoxyphenyl)methylidene]amino}benzenesulfonamide:

Recrystallization from ethanol: C14H14N2O4S; Molecular wt. 306; Yield 58%; m.p.2000C; colour-whitsh yellow; IR (KBr) cm-1 3400cm-1(O-H), 1670 cm-1 (CH=N), 1139 cm-1 (S=O); 1HNMR(DMSO d6) δ,ppm: 3.75 (s,3H,CH), 3.0 (s,1H,OH), 5.2-7.2 (m,3H,Ar-CH), 8.4 (s,1H,CH=N), 7.6 (t,2H,CH), 7.9(t,2H,CH), 2.2(s,2H,SO2NH2). Anal.Calcd.(%):C=54.90, H=4.60, N=9.12, O=20.91, S=10.47.

2(B) 4-[(4-hydroxy-3-methoxybenzylidene)amino]-N-(1,3thiazol-2-yl)benzenesulfonamide:

Recrystallization from ethanol: C17H15N3O4S2; Molecular.wt. 389; Yield 72%; m.p.1500C; colour-yellow; IR (KBr) cm-1 3420cm-1(O-H), 1650 cm-1 (CH=N), 1115 cm-1 (S=O) ; 1HNMR(DMSO d6) δ,ppm: 3.75 (s,3H,CH), 3.0 (s,1H,OH), 5.2-7.2 (m,3H,Ar-CH), 8.4 (s,1H,CH=N),7.6 (t,2H,CH), 7.9 (t,2H,CH), 4.2(s,1H,SO2NH), 6.5-7.5 (m,2H,CH). Anal.Calcd.(%):C=52.40, H=3.91, N=10.70, O=16.52, S=16.47.

2(C)4-[(4-hydroxy-3-methoxybenzylidene)amino]-N-(5-methylisoxazol-2-yl)benzenesulfonami de:

Recrystallization from ethanol: C18H17N3O5S; Molecular wt. 387; Yield 98%; m.p.1900C; colour-pale yellow; IR (KBr) cm-1 3440cm-1(O-H), 1670 cm-1 (CH=N), 1149 cm-1 (S=O); 1HNMR(DMSO d6)δ,ppm:3.75(s,3H,CH), 3.0(s,1H,OH), 5.2-7.2(m,3H,Ar-CH), 8.4(s,1H,CH=N), 7.6(t,2H,CH), 7.9(t,2H,CH), 4.2(s,1H,SO2NH), 5.2(s,1H,CH), 2.5(s,3H,CH3). Anal.Calcd.(%):C=52.30, H=4.01, N=10.70, O=16.52, S=16.47.

2(D)N-(4,6-dimethylpyrimidin-2-yl)-4-{[(E)-(4-hydroxy-3-methoxyphenyl)methylidene]amino } benzene sulfonamide:

Recrystallization from ethanol: C20H20N4O4S; Molecular wt. 412 ; Yield 50%; m.p.1100C; colour-yellow ;IR (KBr) cm-1 3450cm-1(O-H), 1660 cm-1 (CH=N), 1153 cm-1 (S=O); 1HNMR(DMSO d6) δ,ppm: 3.75(s,3H,CH), 3.0(s,1H,OH), 5.2-7.2(m,3H,Ar-CH), 8.4(s,1H,CH=N), 7.6(t,2H,CH), 7.9(t,2H,CH), 4.2(s,1H,SO2NH), 3.8(s,1H,CH), 2.8-3(s,6H,CH3). Anal.Calcd.(%):C=58.20, H=4.93, N=13.50,O=15.60, S=7.77.

2(E) 4-[(5-Methoxy-2-nitro-4-vinyloxymethyl-benzylidene)-amino]-benzenesulfonamide:

Recrystallization from ethanol: C17H17N3O6S; Molecular wt. 391; Yield 66%; m.p.1200C; colour-yellow ; IR (KBr) cm-1 1617 cm-1 (CH=N), 1598 cm-1 (NO2), 1139 cm-1 (S=O); 1HNMR(DMSO d6) δ,ppm:3.75(s,3H,CH), 5.2-7.2(m,2H,Ar-CH), 5.4(s,2H,CH), 6.5(t,1H,CH), 4.2(d,2H,CH), 8.4(s,1H,CH=N), 7.6(t,2H,CH), 7.9(t,2H,CH), 4.2(s,2H,SO2NH2). Anal.Calcd.(%): C=52, H=4.55, N=10.70, O=24.57,S=8.19.

2(F)4-[(5-Methoxy-2-nitro-4-vinyloxymethyl-benzylidene)-amino]-N-thiazol-2-yl-benzene sulfonamide:

Recrystallization from ethanol: C20H18N4O6S2; Molecular wt. 474; Yield 70%; m.p.1100C; colour- brown yellow; IR (KBr) cm-1 1627 cm-1 (CH=N), 1588cm-1 (NO2),1190 cm-1 (S=O);1HNMR(DMSO d6) δ,ppm:3.75(s,3H,CH), 5.2-7.2(m,2H,Ar-CH), 5.4(s,2H,CH), 6.5(t,1H,CH), 4.2(d,2H,CH), 8.4(s,1H,CH=N), 7.6(t,2H,CH), 7.9(t,2H,CH), 4.2(s,1H,SO2NH), 6.5-7.5(m,2H,CH). Anal.Calcd.(%): C=50.30%, H=3.82, N=11.81, O=20.55, S=13.51.


Recrystallization from ethanol: C23H23N5O6S; Molecular wt. 520 ; Yield 60%; m.p.1300C; colour- brown yellow; IR (KBr) cm-1 1620 cm-1 (CH=N), 1542cm-1 (NO2), 1139 cm-1 (S=O) ;1HNMR(DMSO d6)δ,ppm:3.75(s,3H,CH), 5.2-7.2(m,3H,Ar-CH), 5.4(s,2H,CH), 6.5(t,1H,CH),. 2(d,2H,CH), 8.4(s, 1H,CH=N), 7.6(t,2H,CH), 7.9(t,2H,CH), 4.2(s,1H,SO2NH), 3.8(s,1H,CH), 2.8-3 (s, 6H, CH3) . Anal.Calcd. (%):C=55.50, H=4.68, N=14, O=19.37, S=6.44.

2(H)4-[(4-Allyloxy-5-methoxy-2-nitro-benzylidene)-amino]-N-(5-methyl-isoxazol-3-yl)-benzene sulfonamide:

Recrystallization from ethanol: C21H20N4O7S; Molecular wt. 472 ; Yield 70%; m.p.1200C; colour- brown yellow; IR (KBr) cm-1 1640 cm-1 (CH=N), 1540cm-1 (NO2), 1120 cm-1 (S=O) ;1HNMR(DMSO d6)δ,ppm:3.75(s,3H,CH), 5.2-7.2(m,2H,Ar-CH), 5.4(s,2H,CH), 6.5(t,1H,CH), 4.2(d,2H,CH), 8.4 (s,1H,CH=N), 7.6(t,2H,CH), 7.9(t,2H,CH), 4.2(s,1H,SO2NH), 5.2(s,1H,CH), 2.5(s,3H,CH3). Anal.Calcd.: C=53.30, H= 4.35, N=11.80, O= 23.76, S= 6.79.


Recrystallization from ethanol: C17H18N2O4S; Molecular wt. 346; Yield 72%; m.p.750C; colour- yellow; IR (KBr) cm-1 3430cm-1(O-H), 1630 cm-1 (CH=N);1HNMR(DMSO d6) δ,ppm: 3.75(s,3H,CH), 3.0(s,1H,OH), 5.2-7.2(m,2H,Ar-CH), 4.96(d,2H,CH), 6.4(p,1H,CH), 3.5(d,2H,CH), 8.4(s,1H,CH=N), 7.6(t,2H,CH), 7.9(t,2H,CH), 2.2(s,2H,SO2NH2).Anal.Calcd.(%):C=58.90, H=5.28, N=8.09, O=18.47, S=9.27.


Recrystallization from ethanol: C20H19N3O4S; Molecular wt. 429; Yield 80%; m.p.650C; colour- cremish yellow; IR (KBr) cm-1 3410cm-1(O-H), 1650 cm-1 (CH=N); 1HNMR(DMSO d6) δ,ppm:: 3.75(s,3H,CH), 3.0(s,1H,OH), 5.2-7.2(m,2H,Ar-CH), 4.96(d,2H,CH), 6.4(p,1H,CH), 3.5(d,2H,CH), 8.4(s,1H,CH=N), 7.6(t,2H,CH), 7.9(t,2H,CH), 4.2(s,1H,SO2NH), 6.5-7.5(m,2H,CH). Anal.Calcd.(%): C=55.90, H=4.49, N=9.70, O=14.98,S=14.93.

2(K)4-[(3-Allyl-4-hydroxy-5-methoxy-benzylidene)-amino]-N-(5-methyl-isoxazol-3-yl)-benze nesulfonamide:

Recrystallization from ethanol: C21H21N3O5S; Molecular wt. 427; Yield 95%; m.p.700C; colour- cremish white; IR (KBr) cm-1 3400cm-1(O-H), 1670 cm-1 (CH=N) ;1HNMR(DMSO d6) δ,ppm: 3.75(s,3H,CH), 3.0(s,1H,OH), 5.2-7.2 (m,2H,Ar-CH), 4.96(d,2H,CH), 6.4 (p,1H,CH),3.5 (d,2H,CH), 8.4 (s,1H,CH=N), 7.6 (t,2H,CH), 7.9 (t,2H,CH), 4.2 (s,1H,SO2NH),5.2 (s,1H,CH), 2.5 (s,3H,CH3). Anal.Calcd.(%): C=59.00, H=4.98%, N=9.80, O=18.70, S=7.51.

2(L)4-[(3-Allyl-4-hydroxy-5-methoxy-benzylidene)-amino]-N-(4,6-dimethyl-pyrimidin-2-yl)-benzene sulfonamide:

Recrystallization from ethanol: C23H24N4O4S; Molecular wt. 452; Yield 80%; m.p.720C; colour- cremish white ; IR (KBr) cm-1 3450cm-1(O-H), 1640 cm-1 (CH=N), ;1HNMR(DMSO d6) δ,ppm: 3.75(s,3H,CH), 3.0(s,1H,OH), 5.2-7.2(m,2H,Ar-CH), 4.96(d,2H,CH), 6.4(p,1H,CH), 3.5(d,2H,CH), 8.4(s,1H,CH=N), 7.6(t,2H,CH), 7.9(t,2H,CH), 4.2(s,1H,SO2NH), 3.8(s,1H,CH), 2.8-3(s,6H,CH3). Anal.Calcd.(%):C, C=61.10, H=5.30, N=12.38, O=14.14, S=7.09

(3A-L) mp 110-2000C, yield 35%-45%: IR KBr (m cm_1) 3512 (O–H), 1760 (C=O, fourmembered lactam), 1578 (N=N), 1498 (N=O, asym), 1349(N=O, sym), 1602, 1599, 1464 (C–C, ring str), 1H NMR (d) ppm 4.2 (s, 1H, OH), 5.1 (d, 1H, J3,4 = 4.4 Hz, C4–H), 5.8 (d, 1H, J3,4 = 4.4 Hz, C3–H), 7.1–7.4 (m, 12H, ArH),:Elemental analysis, found (calcd) (%) C, 61.23 (61.99): H, 3.18 (3.69); N, 13.41 (13.77) (Table 1).

Table 1.

Physical characteristics of the synthesized azetidin-2-ones. Comp. M.p(0c) Yield Colour
1 3A 2000 35% Black colour
2 3B 1900 40% Yellowish colour
3 3C 2100 40% Black colour
4 3D 1800 45% Reddish brown colour
5 3E 1400 40% Pale yellow colour
6 3F 1300 35% Brown colour
7 3G 1200 40% Black colour
8 3H 1350 40% Black colour
9 3I 1200 45% Black colour
10 3J 1300 35% Black colour
11 3K 1100 40% Brown colour
12 3L 1100 42% Black-brown colour

In disc-diffusion assay, few colonies of organisms were inoculated in 2–5 mL nutrient broth and grown for 2.5 h. The agar plates were dried and inoculated by spreading the fungal suspension evenly over it. The sterile paper discs (6 mm) impregnated with fixed dose viz., 400 lg/mL of compound were placed on the preinoculated surface. The disc-bearing plates were incubated at 37 _C and examined at 48 h for zone of inhibition, if any, around the disc. Chloromycetin was used in assay as a standard control drug. An additional negative control disc without any sample but impregnated with equivalent amount of solvent (DMF) was also used in the assay. The diameter of inhibition zone is directly proportional to the degree of sensitivity of fungal strain and the concentration ofcompound under test .

All the newly synthesized azetidin-2-ones 3(A-L) were assayed in vitro for their growth inhibitory activity against pathogenic micro-organisms. We examine the antifungal potentialities of azetidin-2-ones against pathogenic fungi viz; Aspergillus niger & Aspergillus flavus by disc diffusion assay and compared with Terbiforce as a reference standard. It is observed that Asperilgus aureus show moderate to good activity while Asperilgus flavus show good to maximum inhibition nearly in all compounds (Table 2).

Table 2.

Results of in-vitro antibacterial & Antifungal activity observed for the synthesized azetidin-2-ones compounds through disc diffusion assay.

R R” Inhibition zone diametersa
Asperilgus aureus Asperilgus flavus
3A p-OH H 10 11
3B p-OH 10 14
3C p-OH 11 14
3D p-OH 10 13
3E p- CH2=CH-OCH2, o-NO2 H 12 28
3F p- CH2=CH-OCH2, o-NO2 10 26
3G p- CH2=CH-OCH2, o-NO2 11 26
3H p- CH2=CH-OCH2, o-NO2 - 28
3I p-OH,m-CH2=CH-CH2 H - -
3J p-OH,m-CH2=CH-CH2 11 12
3K p-OH,m-CH2=CH-CH2 12 24
3L p-OH,m-CH2=CH-CH2 12 20
Standard Terbiforce 14 48

Antifungal susceptibility of compounds was measured in terms of zone of growth inhibitions.

(-) means no activity.

aInhibition zone diameters in millimeters at 1000 µg/mL concentration of compounds.


The results of antifungal screening clearly indicate that the nature of substiuents and their position on azetidin-2-ones nucleus affected the in vitro antifungal activity significantly. The presence of electron-withdrawing groups on the aromatic ring in general increases the antifungal activity of tested compounds. It can be concluded that the presence of sulfonyl group in the azetidin-2-ones moiety enhanced the antifungal activity of the compounds. Sulphamethoxazole substituent frequently appears in many drugs and it follows the trend here also as sulphamethoxazole substituted compounds seem to be more potent than other sulpha substituents. Antifungal activity of sulphanilimide and sulphathiazole substituted azetidin-2-ones is average. Here we are able to identify some interesting structure-activity relationship on azetidinone ring. Our results encourage the synthesis of new class substituted azetidin-2-ones analogs showing good antifungal activity.


The authors confirm that this article content has no conflict of interest.


We gratefully acknowledge lab facility from SOS chemistry jiwaji university Gwalior, India and are thankful to the Dean, Birla Institute of Medical Research And College of Life Sciences, India, for providing facilities of biological screening.


[1] Balaban AT, Oniciu DC, Katritzky AR. Aromaticity as a cornerstone of heterocyclic chemistry Chem Rev 2004; 104(5): 2777-812.
[2] Morin RB, Gorman M. Chemistry and Biology of b-lactam Antibiotics. 6th ed. New York: Academic Press 1982.
[3] Brandi A, Cicchi S, Cordero FM. Novel syntheses of azetidines and azetidinones Chem Rev 2008; 108(9): 3988-4035.
[4] Fleming A. On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae Br J Exp Pathol 1929; 10: 226-36.
[5] Knowles JR. Penicillin resistance the chemistry of. beta.-lactamase inhibition Acc Chem Res 1985; 18: 97-104.
[6] Zarei M, Mohamadzadeh M. 3-Thiolated 2-azetidinones: synthesis and in vitro antibacterial and antifungal activities Tetrahedron 2011; 67: 5832-40.
[7] Noolvi M, Agrawal S, Patel H, Badiger A, Gaba M, Zambre A. Synthesis, antimicrobial and cytotoxic activity of novel azetidine-2-one derivatives of 1H-benzimidazole Arab J Chem 2011; 02: 11.
[8] Kaura A, Sharma L, Dharb VJ. Synthesis, spectral and antimicrobial study of Some novel schiff bases and beta-lactam Derivatives Int J Chem Sci 2011; 9: 2009-15.
[9] Dubey A, Srivastava SK, Srivastava SD. Conventional and microwave assisted synthesis of 2-oxo-4-substituted aryl-azetidine derivatives of benzotriazole: a new class of biological compounds Bioorg Med Chem Lett 2011; 21(1): 569-73.
[10] Sharma R, Samadhiya P, Srivastava SD, Srivastava SK. Synthesis and pharmaceutical importance of 2-azetidinone derivatives of phenothiazine J Chem Sci 2012; 124: 633-7.
[11] Saundane AR, Yarlakatti M, Katkar VK. Synthesis, antioxidant and antimicrobial evaluation of thiazolidinone, azetidinone encompassing indolylthienopyrimidines J Chem Sci 2012; 124: 469-81.
[12] Pathak RB, Chovatia PT, Parekh HH. Synthesis, antitubercular and antimicrobial evaluation of 3-(4-chlorophenyl)-4-substituted pyrazole derivatives Bioorg Med Chem Lett 2012; 22(15): 5129-33.
[13] Chopde HN, Meshram JS, Pagadala R. Synthesis, characterization and antibacterial evaluation of some azetidinone derivatives of 3-methyl-1H-pyrazol-5(4H)-one Archives. Appl Sci Res 2012; 4(3): 1442-6.
[14] Mashelkar UC, Jha MS, Mashelkar BU. Synthesis of 2-azetidinones substituted coumarin derivatives J Serb Chem Soc 2012; 77: 1339-44.
[15] Singh P, Raj R, Kumar V, et al. 1,2,3-Triazole tethered β-lactam-chalcone bifunctional hybrids: synthesis and anticancer evaluation Eur J Med Chem 2012; 47(1): 594-600.
[16] Kayarmar R, Nagaraja GK, Naik P, Manjunatha H, Revanasiddappa BC, Arulmoli T. Synthesis and characterization of novel imidazoquinoline based 2-azetidinones as potent antimicrobial and anticancer agents J Saudi Chem Society 2014.
[17] Galletti P, Soldati R, Pori M, et al. Targeting integrins avb3 and a5b1 with new b-lactam derivatives Eur J Med Chem 2014; 83: 284-93.
[18] Staüdinger H. Zur Kenntniss der Ketene: Diphenylketen Justus Liebigs Ann Chem 1907; 356: 51-123.
[19] Banik BK, Becker FF. Heterocycles Tetrahedron Lett 2000; 4: 6551-4.
[20] Junne SB, Kadam AB, Zangade SB, Shinde SL, Vibhute YB. Synthesis of benzthiazole derivatives grouping with substituted azetidinone ring and its functional behavior Int Multidiscip Res J 2012; 2: 44-7.
[21] Singh GS, Mbukwa E, Pheko T. Synthesis and antimicrobial activity of new 2-azetidinones from N-(salicylidene) amines and 2-diazo-1,2-diarylethanones ARKIVOC 2007; IX: 80-90.
[22] Bhat IK, Mishra SK, James JP, Shastry CS. Antimicrobial studies of synthesized azetidinone derivatives from sulfamethoxazole moiety J Chem Pharm Res 2011; 3: 114-8.
[23] Hussain S, Jadhav S, Rai M, Farooqui M. Synthesis, Characterization and Biological Evaluation of N [3-Chloro-2 (aryl)-4-oxoazitidin-1-y] pyridine-4-carboxamide Int J Drug Des Discov 2011; 2: 527-32.
[24] Nikalje AP, Pathana M, Narute AS, Ghodke MS, Rajani D. Synthesis and QSAR Study of Novel N-(3-chloro-2-oxo-4-substituted azetidin-1-yl) isonicotinamide derivatives as Anti mycobacterial Agents Der Pharm. Sin 2012; 3: 229-38.
[25] Samadhiya P, Sharma R, Srivastava SK, Srivastava SD. Synthesis of 2-azetidinone derivatives of 6-nitro-1h-indazole and their biological importance Quim Nova 2012; 35: 914-9.
[26] O’Boyle NM, Greene LM, Bergin O, et al. Synthesis, evaluation and structural studies of antiproliferative tubulin-targeting azetidin-2-ones Bioorg Med Chem 2011; 19(7): 2306-25.
[27] Gerona-Navarro G, Pérez de Vega MJ, García-López MT, et al. From 1-acyl-beta-lactam human cytomegalovirus protease inhibitors to 1-benzyloxycarbonylazetidines with improved antiviral activity. A straightforward approach to convert covalent to noncovalent inhibitors J Med Chem 2005; 48(7): 2612-21.
[28] Arya N, Munde MK, Dwivedi J, Jagdale AY, Jain KS. Design, synthesis, and antihyperlipidemic evaluation of novel 2-[1-(substitutedphenyl)-4-oxo-azetidin-2-yl]-5,6-disubstitutedthieno[2,3-d]pyrimidin-4(3H)-ones Arch Pharm (Weinheim) 2013; 346(8): 588-95.
[29] Reddy DR, Namratha RJ. Synthesis and biological evaluation of 6-fluoro benzothiazole substitutedpyrazolo azetidinones Der Pharma Chem 2013; 5: 235-40.
[30] Bisacchi GS, Slusarchyk WA, Bolton SA, et al. Synthesis of potent and highly selective nonguanidine azetidinone inhibitors of human tryptase Bioorg Med Chem Lett 2004; 14(9): 2227-31.
[31] Experimental: All melting points were measured in open capillary and are uncorrectedThe chemicals and reagents used were of AR grade The product mixtures were analyzed by thin-layer chromatography (TLC) on silica gel sheets IR spectra (in cm_1) were recorded on PerkinElmer 337 spectrometer 1H NMR was recorded on a Varian EM-390 MHz NMR spectrometer in DMSO-d6, chemical shifts are given in d ppm using TMS as an internal standard Mass spectral analysis was performed on Jeol SX-102 spectrometer using FAB technique
[32] General procedure for the synthesis of imines [2A-L]: An equimolar mixture (0005 M) of aldehyde and appropriate amine in ethanol was refluxed for 3 h The reaction mixture was cooled in an ice bath and a drop of sulfuric acid was added to it The product obtained was filtered, washed and recrystallised by EtOH as shiny yellow crystals
[33] General procedure for the synthesis of β-lactam [3A-L]: In a closed vessel containing compound (0001 M) in 20 mL of 1,4-dioxan, 0095 mL of chloroacetyl chloride and 016 mL of triethylamine were added and the reaction mixture was stirred at 50 _C for 1 h The reaction mixture was then kept at room temperature for 30 min and further refluxed for 8 hThe filtrate was concentrated under reduced pressure and poured into ice-cold water The product so obtained was recrystallised from methanol as light brown crystals